You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

RNA Virus Infections

Showing 26 - 50 of >10,000
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

AIDS, HIV Infection, RNA Virus Infections Trial in Kericho (HIV-1 viral load testing)

Completed
  • Acquired Immunodeficiency Syndrome
  • +3 more
  • HIV-1 viral load testing
  • Kericho, Kenya
    Kenya Medical Research Institute/ Walter Reed Project HIV Progra
Jul 13, 2020

Occurrence of Antibodies Cross-reacting With Autoantigens in

Recruiting
  • Epstein-Barr Virus (EBV) Infection
  • Data collection: Participant characteristics (Illness course, complications of primary EBV infection and provided treatments)
  • +2 more
  • Basel, Switzerland
    University Hospital Basel, Division of Internal Medicine
Nov 8, 2021

Virus Diseases, RNA Virus Infections, Respiratory Tract Diseases Trial in Miami (Low dose of quadrivalent VLP vaccine, Medium

Completed
  • Virus Diseases
  • +3 more
  • Low dose of quadrivalent VLP vaccine
  • +3 more
  • Miami, Florida
    Miami Research Associates
Jun 8, 2020

Virus Diseases, RNA Virus Infections, Respiratory Tract Infections Trial in Canada (Quadrivalent VLP Influenza Vaccine)

Completed
  • Virus Diseases
  • +3 more
  • Quadrivalent VLP Influenza Vaccine
  • Halifax, Nova Scotia, Canada
  • +9 more
Jun 8, 2020

SARS-CoV-2 Virus, Severe Acute Respiratory Syndrome Coronavirus 2, COVID-19 Trial (Bivalent BNT162b2 (original/Omicron

Not yet recruiting
  • SARS-CoV-2 Virus
  • +2 more
  • Bivalent BNT162b2 (original/Omicron BA.4/BA.5) 3 microgram dose
  • +4 more
  • (no location specified)
Sep 14, 2022

Virus Diseases, RNA Virus Infections, Respiratory Tract Diseases Trial in Toronto, Pierrefonds (Low dose of H5 VLP vaccine +

Completed
  • Virus Diseases
  • +3 more
  • Low dose of H5 VLP vaccine + Alhydrogel
  • +5 more
  • Toronto, Ontario, Canada
  • +1 more
Jun 8, 2020

Covid19, SARS-CoV Infection, Corona Virus Infection Trial in Singapore, United States (ARCT-021 single dose priming, ARCT-021

Terminated
  • Covid19
  • +2 more
  • ARCT-021 single dose priming
  • +5 more
  • Chandler, Arizona
  • +14 more
Jul 7, 2022

Virus Diseases, RNA Virus Infections, Respiratory Tract Diseases Trial in Canada, United States (15 µg/strain of Quadrivalent

Completed
  • Virus Diseases
  • +3 more
  • 15 µg/strain of Quadrivalent VLP Vaccine
  • +2 more
  • Hollywood, Florida
  • +8 more
Jun 8, 2020

Adenovirus Infection, BK Virus Infection, Cytomegaloviral Infection Trial in Houston (Virus-specific Cytotoxic T-lymphocytes)

Recruiting
  • Adenovirus Infection
  • +6 more
  • Virus-specific Cytotoxic T-lymphocytes
  • Houston, Texas
    M D Anderson Cancer Center
Jan 6, 2023

Host Genetic Factors Underlying Ebola Virus Disease Risk,

Completed
  • Ebola Virus Disease
    • Kalkata, Liberia
    • +3 more
    Aug 18, 2022

    Immune Function and PD-1 Antibody Therapy Efficacy Predictors on

    Recruiting
    • Secondary Hemophagocytic Lymphohistiocytosis
    • Chronic Active Epstein-Barr Virus Infection
    • No intervention
    • Beijing, Beijing, China
      Beijing Friendship Hospital, Capital Medical University
    May 2, 2023

    Study of Transfusion-Transmitted Infections

    Completed
    • Viral Disease
    • +2 more
      • Bethesda, Maryland
        National Institutes of Health Clinical Center
      Jan 25, 2023

      CMV Infection, EBV Infection, Stem Cell Transplant Trial (Virus specific T cells)

      Not yet recruiting
      • CMV Infection
      • +2 more
      • Virus specific T cells
      • (no location specified)
      Oct 4, 2023

      Human Immunodeficiency Virus-type 1 Infection Trial in Worldwide (Rilpivirine, Efavirenz, Tenofovir disoproxil fumarate)

      Completed
      Has Results
      • Human Immunodeficiency Virus-type 1 Infection
      • Douala, Cameroon
      • +17 more
      Jan 22, 2021

      Chronic Hepatitis Delta Virus Infection Trial (HH-003(20mg/kg), HH-003(10mg/kg), TAF)

      Not yet recruiting
      • Chronic Hepatitis Delta Virus Infection
      • HH-003(20mg/kg)
      • +2 more
      • (no location specified)
      May 7, 2023

      Respiferon Project

      Recruiting
      • Respiratory Viral Infection
      • Evaluate the performance of IFN I/III
      • Lyon, Rhone, France
        Infective Agents Institute, Croix rousse Hospital
      Aug 24, 2023

      Herpes Virus Infections in Kidney Transplant Patients

      Recruiting
      • Kidney Transplant; Complications
      • +2 more
        • Aarhus, Denmark
        • +4 more
        Jan 30, 2023

        Adenovirus, Cytomegalovirus Infections, Epstein-Barr Virus Infections Trial in Pittsburgh (Specific T- Lymphocytes)

        Not yet recruiting
        • Adenovirus
        • +2 more
        • Specific T- Lymphocytes
        • Pittsburgh, Pennsylvania
          UPMC Children's Hospital of Pittsburgh
        Sep 8, 2023

        Respiratory Syncytial Virus Infection Trial (Sisunatovir, Placebo)

        Not yet recruiting
        • Respiratory Syncytial Virus Infection
        • (no location specified)
        Oct 6, 2023

        Virus Diseases, RNA Virus Infections, Respiratory Tract Diseases Trial in Worldwide (Quadrivalent VLP Vaccine, Placebo)

        Completed
        • Virus Diseases
        • +3 more
        • Quadrivalent VLP Vaccine
        • Placebo
        • Mobile, Alabama
        • +72 more
        Oct 29, 2020

        SARS-CoV-2 Virus Trial in Bangkok (SARS-CoV-2 RNA detection)

        Completed
        • SARS-CoV-2 Virus
        • SARS-CoV-2 RNA detection
        • Bangkok, Thailand
          2 Division of Nephrology,Department of Medicine Pramongkutklao H
        Aug 31, 2023

        Respiratory Syncytial Virus Disease in Infants and Toddlers

        Not yet recruiting
        • Respiratory Syncytial Virus Infections
          • (no location specified)
          Jul 27, 2023

          Shingles, Herpes Zoster Infection, Human Trial (Candidate 1: PF-07915234: VZV modRNA Powder for Suspension for Injection,

          Not yet recruiting
          • Shingles
          • +2 more
          • Candidate 1: PF-07915234: VZV modRNA Powder for Suspension for Injection
          • +6 more
          • (no location specified)
          Jan 19, 2023

          Human Immunodeficiency Virus Infections Trial in India (Rilpivirine 25 mg, Tenofovir Disoproxil Fumarate (TDF)/Lamivudine (3TC))

          Terminated
          • Human Immunodeficiency Virus Infections
          • Rilpivirine 25 mg
          • Tenofovir Disoproxil Fumarate (TDF)/Lamivudine (3TC)
          • Bengaluru, India
          • +5 more
          Jun 23, 2022

          Influenza, Human Trial (Clarithromycin 250 MG, Placebos)

          Suspended
          • Influenza, Human
          • Clarithromycin 250 MG
          • Placebos
          • Hong Kong, Hong Kong
            School of Public Health, The University of Hong Kong
          Nov 1, 2022